Since October 2011 the PHIS website is no longer maintained.
Please refer from now on to the website of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies: http://whocc.goeg.at.
Publication of the PHIS Hospital Pharma Report
The PHIS Hospital Pharma Report, which was compiled by PHIS project leader GÖG/ÖBIG
together with WP Hospital Pharma leader SUKL, allows gaining insight into medicines
management in hospitals. The report offers an overview on purchasing policies and
financing strategies for medicines in the in-patient sector in 27 countries (European
overview) and case studies including a price comparison in 25 hospitals in five
countries (Austria, Norway, the Netherland, Portugal, Slovakia). More information
can be obtained here PHIS Hospital
The main findings of the PHIS Hospital Pharma Report were translated into German
and are also available under the section
PHIS Hospital Report
PHIS (Pharmaceutical Health Information System) is an European Commission funded
project, commissioned by the Executive
Agency for Health and Consumers under the call for proposals 2007 in the
priority area "health information" of the European Commission, DG Sanco, and co-funded by the Austrian Ministry of Health.
The PHIS project runs from September 2008 to April 2011 (32 months).
The PHIS project aims at increasing knowledge and exchange of information on pharmaceutical
policies, in particular on pricing and reimbursement, in the EU Member States, covering
both the out-patient and the in-patient sector.
This will be done via different work packages resulting in the following deliverables:
- the PHIS Glossary with
key terms related to pharmaceuticals
- the PHIS Library, offering
country specific information on out-patient and in-patient pharmaceutical pricing
and reimbursement for the EU Member States
- the PHIS Indicators and the
PHIS Database, containing key data for the developed indicators in the EU Member
- the PHIS Hospital Pharma
Report with information on pharmaceutical policies in the inpatient sector in
the EU Member States, including a price survey
- the PHIS network comprising
national representatives (competent authorities, Third Party Payers, hospital associations)
and European stakeholders in the field of pharmaceuticals.
The PHIS project management
is a consortium of the project leader
Gesundheit Österreich GmbH, Geschäftsbereich Österreichisches Bundesinstitut für
Gesundheitswesen / Austrian Health Institute (GÖG/ÖBIG) a research institute
situated in Vienna, Austria, and four associated partners: the Italian Medicines Agency (AIFA), Italy, the International Healthcare and Health Insurance Institute
SOGETI Luxembourg SA., Luxembourg and the
State Institute for Drug Control (SUKL), Slovakia.
Further key stakeholders of the PHIS project management are the
PHIS advisory board covering EU Commission services and agencies and international
organisations, and the PHIS network,
which comprises national representatives from competent authorities and further
relevant institutions from the EU Member States and associated countries.
A brief description of the PHIS project can be found in the